11 June 2020
Clinical tests of a vaccine against the novel coronavirus may begin in Spain in the autumn of 2020, Science and Innovation Minister Pedro Duque told TASS in an interview.
“Work is in progress in Spain on ten vaccine projects,” Duque said. Currently a team of specialists under virologist Mariano Esteban, of the National Center of Biotechnology, is testing one vaccine on mice.
“If the results are satisfactory, clinical tests may begin in the autumn,” Duque said. “It is expected that preclinical tests of several other vaccines will begin by the end of the year.”
“I do believe that we will be able to obtain a vaccine in sufficient amounts during 2021,” he said. “however, success is not guaranteed. There are many diseases against which no vaccines have been created to this day.”
“But it is also true that such vast research has never been carried out at scientific centres, universities and private companies,” Duque said. “Currently laboratories around the world are working on some 180 projects for creating a vaccine against SARS-CoV-2.”
In all previous cases creating and authorizing a newly-created vaccine for use required several years. This time, amid the coronavirus pandemic the regulatory authorities are trying to fast-track the procedure.
“One of the risks [resulting from haste] is the emergence of a vaccine that has been produced but not tested well enough and will eventually fail to work,” Duque said.
“Spain favours cooperation with all countries, including Russia, of course,” he said. “from the very beginning of this crisis we called for open access to all results that have been obtained. it is a common problem and all of us should cooperate to resolve it.”
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Putin has stated that Russia will support Africa in the struggle against epidemics
19 April 2024
The Russian government has expanded the list of vital and essential drugs
19 April 2024
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024